Compare AMPH & WLFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AMPH | WLFC |
|---|---|---|
| Founded | 1996 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Specialties |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.3B |
| IPO Year | 2005 | 1997 |
| Metric | AMPH | WLFC |
|---|---|---|
| Price | $20.02 | $201.60 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $30.33 | N/A |
| AVG Volume (30 Days) | ★ 319.0K | 24.6K |
| Earning Date | 06-01-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 0.79% |
| EPS Growth | N/A | ★ 146.23 |
| EPS | 2.03 | ★ 13.89 |
| Revenue | ★ $719,887,000.00 | $569,223,000.00 |
| Revenue This Year | $8.00 | $16.17 |
| Revenue Next Year | $4.42 | $1.26 |
| P/E Ratio | $17.70 | ★ $14.59 |
| Revenue Growth | N/A | ★ 36.00 |
| 52 Week Low | $20.39 | $114.01 |
| 52 Week High | $31.26 | $211.00 |
| Indicator | AMPH | WLFC |
|---|---|---|
| Relative Strength Index (RSI) | 19.78 | 61.36 |
| Support Level | N/A | $192.00 |
| Resistance Level | $29.30 | $206.77 |
| Average True Range (ATR) | 1.15 | 6.50 |
| MACD | -0.67 | -1.37 |
| Stochastic Oscillator | 2.02 | 63.79 |
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.
Willis Lease Finance Corp, with its subsidiaries, is a lessor and servicer of commercial aircraft and aircraft engines. The company has two reportable business segments, which include Leasing and Related Operations and Spare Parts Sales. A majority of its revenue is generated from the Leasing and Related Operations segment, which involves acquiring and leasing, under operating leases, commercial aircraft, aircraft engines, and other aircraft equipment and the selective purchase and resale of commercial aircraft engines, aircraft equipment, and other related businesses. Geographically, the company derives maximum revenue from the United States, followed by Europe, Asia-Pacific (excluding India), India, South America, Canada, Central America, and the Middle East.